Laurus Labs Ltd share price logo

Laurus Labs Share Price

NSE: LAURUSLABS

BSE: 540222

Mid Cap

Healthcare Sector

₹1021.20

-16.25

(-1.57%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Laurus Labs Stock Performance

as on February 19, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,016.00
    ₹1,044.80
    downward going graph

    0.51%

    Downside

    2.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹512.35
    ₹1,141.00
    downward going graph

    49.83%

    Downside

    11.73%

    Upside

    downward going graph

Laurus Labs share price movements today

Previous Close
₹1,037.45
Open
₹1,044.80
Volume
11.53L
Upper Circuit
₹1,141.15
Lower Circuit
₹933.75
Day's Low - High
₹1,016.00 - ₹1,044.80
52 Week Low - High
₹512.35 - ₹1,141.00

Laurus Labs Historical Returns

1 Month Return
-2.38 %
3 Month Return
+ 5.06 %
1 Year Return
+ 89.75 %
3 Year Return
+ 212.96 %
5 Year Return
+ 183.96 %

Laurus Labs Fundamentals

as on February 19, 2026 at 4:01 pm IST

Market Cap

₹56,007.42 Cr

Return on Equity (ROE)

7.75

PE Ratio (TTM)

66.33

Return on capital employed (ROCE)

9.14

Industry PE ratio

41.52

Beta (LTM)

1.09

P/B Ratio

7.25

Dividend Yield

0.2

PEG Ratio

5.56

Quarterly Earnings Growth YOY

179.34

EPS (TTM)

6.57

Sector

Pharmaceuticals

Book Value

82.94

Technical Analysis

Bullish

View Technical Analysis

Laurus Labs Stock Valuation

as on February 19, 2026 at 4:01 pm IST

Laurus Labs in the last 5 years

  • Overview

  • Trends

Lowest (16.96x)

March 28, 2023

Industry (41.52x)

February 18, 2026

Today (66.33x)

February 18, 2026

Highest (242.70x)

December 6, 2024

LowHigh

Today’s Price to Earnings Ratio: 66.33x

Laurus Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Laurus Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD56,007.4236.79%0.713545,553
Dr Lal Pathlabs Ltd image
Dr Lal Pathlabs Ltd
BUY23,549.863.15%0.544922,461
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
HOLD65,330.3218%0.592,21612,964
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY10,469.2312.82%0.65143704
Thyrocare Technologies Ltd image
Thyrocare Technologies Ltd
BUY6,647.396.93%0.5390687
See all

Market expectation of Laurus Labs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

35.71%

Buy

21.43%

Hold

42.86%

Sell

Laurus Labs Stock’s Investor Sentiment and Interest

Investment in Laurus Labs Ltd Shares on INDmoney has grown by 55.70% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:55.70% versus previous 30 day period

Search interest for Laurus Labs Ltd Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Laurus Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,380.9
1,181.79
1,224.45
1,194.92
1,439.67
1,194.91
1,223.7
1,415.05
1,720.3
1,569.57
1,653.47
1,778.29
Other Income
1.71
3.6
1.78
2.43
18.53
2.51
4.6
9.42
58.57
10.43
26.96
5.76
Total Income
1,382.61
1,185.39
1,226.23
1,197.35
1,458.2
1,197.42
1,228.3
1,424.47
1,778.87
1,580
1,680.43
1,784.05
Expenses
1,095.36
1,015.07
1,036.58
1,013.5
1,198.18
1,023.71
1,045.37
1,129.9
1,299.7
1,187.44
1,250.21
1,298.08
Operating Profit
285.54
166.72
187.87
181.42
241.49
171.2
178.33
285.15
420.6
382.13
403.26
480.21
Operating Profit Margin %
20.68%
14.11%
15.34%
15.18%
16.77%
14.33%
14.57%
20.15%
24.45%
24.35%
24.39%
27%
Profit Before Interest, Tax and Depreciation
287.25
170.32
189.65
183.85
260.02
173.71
182.93
294.57
479.17
392.56
430.22
485.97
Interest
53.1
39.19
42.39
50.82
50.5
49.19
52.61
57.8
56.4
51.5
40
38.79
Depreciation
87.01
90.55
93.37
98.41
102.25
106.06
107.51
106.09
110.43
116.84
120.49
120.62
Profit Before Tax
147.14
40.58
53.89
34.62
107.27
18.46
22.81
130.68
312.34
224.22
269.73
326.56
Tax Paid
39.9
12.18
14.57
9.45
31.95
6.25
5.09
40.07
78.47
63.14
75.98
73.45
Profit After Tax
107.24
28.4
39.32
25.17
75.32
12.21
17.72
90.61
233.87
161.08
193.75
253.11
Total Net profit including share of profit / Loss from associate company
105.27
26.79
37.12
23.34
75.02
12.68
19.95
92.94
232.77
161.68
194.49
251.88
EPS
1.9
0.46
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
Actual EPS
1.9
0.46
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
Adjusted EPS
1.9
0.46
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
Diluted EPS
1.9
0.46
0.68
0.43
1.4
0.23
0.37
1.71
4.33
3.02
3.61
4.65

Laurus Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,904.65
2,056.17
2,291.92
2,831.72
4,813.51
4,935.57
6,040.55
5,040.83
5,553.96
Other Income
33.44
29.19
16.15
5.92
23.66
15.3
6
26.34
75.1
Total Income
1,938.09
2,085.36
2,308.07
2,837.64
4,837.17
4,950.87
6,046.55
5,067.17
5,629.06
Expenses
1,497.01
1,642.85
1,935.93
2,267.17
3,262.83
3,513.14
4,448.36
4,263.33
4,498.68
Operating Profit
407.64
413.32
355.99
564.55
1,550.68
1,422.43
1,592.19
777.5
1,055.28
Operating Profit Margin %
21.4%
20.1%
15.53%
19.94%
32.22%
28.82%
26.36%
15.42%
19%
Profit Before Interest, Tax and Depreciation
441.07
442.51
372.13
570.47
1,574.34
1,437.73
1,598.19
803.84
1,130.38
Interest
99.9
79.64
88.19
89.59
68.16
102.39
165.17
182.9
216
Depreciation
105.98
125.45
164.19
187.27
205.07
251.49
324.08
384.58
430.09
Profit Before Tax
235.19
237.42
119.75
293.61
1,301.11
1,083.85
1,108.94
236.36
484.29
Tax Paid
43.86
69.81
25.99
38.34
317.29
251.42
312.3
68.15
129.88
Profit After Tax
191.33
167.61
93.76
255.27
983.82
832.43
796.64
168.21
354.41
Total Net profit including share of profit / Loss from associate company
190.27
167.61
93.76
255.27
983.82
832.23
793.43
162.27
358.34
EPS
20.78
15.83
8.83
4.78
18.36
15.42
14.69
2.98
6.65
Actual EPS
20.78
15.83
8.83
4.78
18.36
15.42
14.69
2.98
6.65
Adjusted EPS
4.16
3.17
1.77
0.96
18.36
15.42
14.69
2.98
6.65
Diluted EPS
20.78
15.76
8.8
4.78
18.28
15.35
14.64
2.98
6.64

Laurus Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
181.97
331.99
342.49
297.66
347.42
733
911.1
993.9
665.69
601.65
Cash Flow from Investing Activities
-312.01
-288.76
-384.16
-252.93
-221.04
-940.93
-914.47
-996.94
-822.25
-680.33
Cash Flow from Financing Activities
103.32
-53.61
42.25
-44.77
-127.66
254.7
30.26
-26.64
249.83
39.28
Net Cash Flow
-26.72
-10.38
0.58
-0.04
-1.28
46.77
26.89
-29.68
93.27
-39.4

Laurus Labs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
27.2%
27.2%
27.2%
27.19%
27.19%
27.18%
27.18%
27.62%
27.62%
27.59%
27.59%
27.49%
DII
9.74%
10.14%
10.71%
10.77%
11.77%
13.56%
13.05%
12.74%
11.77%
11.94%
11.73%
12.43%
FII
0.02%
0%
0%
0%
25.97%
25.67%
26.08%
25.56%
25.52%
25.7%
26.16%
26.52%
Public
40.64%
39.93%
37.76%
36.29%
35.07%
33.59%
33.69%
34.08%
35.09%
34.77%
34.51%
33.56%
Total Outstanding Shares
53,86,50,925
53,86,50,925
53,86,50,925
53,89,65,858
53,89,65,858
53,91,59,314
53,91,59,314
53,92,52,491
53,92,52,491
53,98,24,899
53,98,24,899
53,98,56,582
Total Shareholders
4,18,615
4,17,977
4,02,640
3,82,880
3,56,830
3,24,059
3,09,063
2,92,214
2,92,905
2,80,223
2,83,678
2,80,756

Mutual Funds that own Laurus Labs Stock

Check out the Mutual Funds with significant holdings in Laurus Labs.

Laurus Labs Corporate Actions

View detailed summary of the earnings and dividend history of Laurus Labs.

  • Laurus Labs Ltd Earnings Results

    Laurus Labs Ltd’s net profit jumped 172.65% since last year same period to ₹251.66Cr in the Q3 2025-2026. On a quarterly growth basis, Laurus Labs Ltd has generated 29.08% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Laurus Labs Ltd Dividends October,2025

    In the quarter ending September 2025, Laurus Labs Ltd has declared dividend of ₹0.80 per share on 23 Oct 2025 - translating a dividend yield of 0.19%.

    Read More about Dividends

Indices Featuring Laurus Labs Stock

Check stock indices that include Laurus Labs.

Nifty Alpha 50

₹50,660.60

-1.43 (▲735.25%)

BSE Healthcare

₹43,040.27

-0.66 (▲286.80%)

S&P BSE 250 LargeMidCap

₹10,942.88

-1.48 (▲164.68%)

S&P BSE Momentum

₹2,196.35

-1.68 (▲37.46%)

NIFTY PHARMA

₹22,429.10

-0.50 (▲112.85%)

S&P BSE 400 MidSmallCap

₹11,744.75

-1.42 (▲168.60%)

Nifty Small 100

₹17,020.35

-1.27 (▲218.90%)

Nifty Smallcap 50

₹8,335.15

-1.44 (▲121.60%)

Nifty Healthcare

₹14,521.20

-0.51 (▲74.65%)

Nifty MidSmallcap 400

₹19,651.60

-1.44 (▲286.85%)

Nifty Smallcap 250

₹15,988.00

-1.19 (▲192.85%)

S&P BSE 150 MidCap

₹16,014.19

-1.54 (▲250.09%)

BSE 500

₹36,523.88

-1.45 (▲538.47%)

Nifty 500

₹23,297.45

-1.47 (▲348.35%)

Insights on Laurus Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 163.02 Cr → 251.66 Cr (in ₹), with an average increase of 19.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LAURUSLABS stock has moved up by 89.8%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.53% to 9.49% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LAURUSLABS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 26.16% to 26.52% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.58K Cr → 1.78K Cr (in ₹), with an average increase of 5.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LAURUSLABS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 34.51% to 33.56% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 27.59% to 27.49% in Dec 2025 quarter

Laurus Labs Stock Futures & Options Contracts

View the latest movement in Laurus Labs Futures & Options, including strike prices, expiry dates, and percentage changes.

Laurus Labs Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LAURUSLABS 24 Feb ₹1050 Call
February 24, 2026
₹1050
₹2.6
-7.75
-74.88%
LAURUSLABS 24 Feb ₹1040 Call
February 24, 2026
₹1040
₹4.15
-10.15
-70.98%
LAURUSLABS 24 Feb ₹1060 Call
February 24, 2026
₹1060
₹1.8
-5.75
-76.16%
LAURUSLABS 24 Feb ₹1100 Call
February 24, 2026
₹1100
₹0.7
-1.55
-68.89%

Laurus Labs Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LAURUSLABS 24 Feb Fut
February 24, 2026
-
₹1015.7
-22.63
-2.18%
LAURUSLABS 30 Mar Fut
March 30, 2026
-
₹1022.1
-22.78
-2.18%
LAURUSLABS 28 Apr Fut
April 28, 2026
-
₹1027.9
-23.45
-2.23%

About Laurus Labs Ltd

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in the production of generic active pharmaceutical ingredients (APIs) in high-growth therapeutic areas like antiretrovirals (ARVs), Hepatitis C, and Oncology. The company operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh, and has invested significantly in their RD and manufacturing infrastructure, having launched 59 products since its inception in 2005. Its key customers include Aspen Pharmacare Limited, Aurobindo Pharma Limited, Cipla Limited, Mylan Laboratories Limited, NATCO Pharma, Strides Shasun, among others. It has 34 owned patents plus 152 pending patent applications in various countries. It is increasingly focused on their integrated generics finished dosage forms FDFs business, having acquired of Sriam Labs and Richcore Lifesciences in the recent years. During 2020, it launched Hydroxychloroquine, initiated TLD supplies for the Global Fund tender, and bargained partnerships with various private and public organizations. On 2022, it infused capital in Laurus Generics Inc . and infused around Rs 46 crore to acquire a stake in Immunoadoptive Cell Therapy Private Limited, among other expansions and operations.

Revenue: ₹1,778.29Cr as on December 2025 (Q3 FY26)
Net Profit: ₹253.11Cr as on December 2025 (Q3 FY26)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
OrganisationLaurus Labs Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOM V G Rao
E-voting on sharesClick here to vote

FAQs

What is Laurus Labs share price today?

Laurus Labs share price today stands at ₹1021.2 as on at the close of the market. Laurus Labs share today touched a day high of ₹1044.8 and a low of ₹1016.

What is the 52 week high and 52 week low range for Laurus Labs share?

Laurus Labs touched a 52 week high of ₹1141 and a 52 week low of ₹512.35. Laurus Labs share price today i.e. is closed at ₹1021.2, which is -10.50% down from its 52 week high and 99.32% up from its 52 week low.

What is Laurus Labs's market capitalisation today?

Laurus Labs market capitalisation is ₹56,007.42 Cr as on .

How to buy Laurus Labs shares?

To buy Laurus Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LAURUSLABS or Laurus Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Laurus Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Laurus Labs trading volume today?

Laurus Labs trading volume is 11.53L as on . This means that 11.53L shares of Laurus Labs were bought and sold on the stock market during today's trading session.